Continuous glucose monitoring for type 2 diabetes patients is gaining exposure in the literature with positive evidence accumulating. Examples follow.
Numerous studies have shown continuous glucose monitoring (CGM) to be beneficial for patients with type 1 diabetes (T1D). Until recently, evidence for the use of CGM for patients with T2D has been lacking.
Studies and reviews published in 2021 are now addressing the use of CGM for patients with T2D, especially those in primary care. Scroll through the slides below for concise summaries of key findings.